查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球孕產婦保健市場 2023-2030
市場調查報告書
商品編碼
1350998

全球孕產婦保健市場 2023-2030

Global Maternal Health Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030 年），全球孕產婦保健市場將以 9.0% 的年複合成長率成長。市場的成長歸因於對採用基於證據的最佳實踐的需求不斷成長，這些最佳實踐可以帶來更好的孕產婦和嬰兒健康結果。如今，在患者護理品質、安全性以及孕婦和產後患者的可及性方面採用最高標準的醫院已獲得認證，以向消費者介紹這些機構。因此，市場參與者正在推出新產品來滿足新節目的需求。例如，2022 年，醫療保險和醫療補助服務中心 (CMS) 在其孕產婦和嬰兒健康計劃中啟動了一項新計劃，旨在減少低風險剖腹產，以增強嬰兒和孕產婦健康。該計劃的核心是學習合作，為醫療補助和 CHIP 機構提供防止低風險剖腹產的策略，並直接與各州合作，在其州採用經過研究證明的最佳實踐。

細分市場前景

全球孕產婦保健市場按類型、併發症和護理進行細分。依類型，市場分為子宮內、異位、輸卵管等。依併發症，市場細分為流產、早產、子癎前症、妊娠糖尿病、前置胎盤等。此外，根據護理，市場分為產前護理和產後護理。在併發症中，由於全球流產增加導致對孕產婦保健的需求不斷成長，預計流產細分市場將佔據相當大的市場佔有率。例如，根據美國國立衛生研究院（NIH）的數據，到2022年，20歲至30歲、妊娠不足20週的女性流產的機率為8.9%。對於40歲以上的女性，這一比例上升至74.7%。既往產科史是早期流產風險的重要預測因子。一次流產、兩次連續流產或三次或以上連續流產後，下次妊娠流產的幾率分別約為 20%、28% 和 43%。

預計妊娠糖尿病細分市場將在全球孕產婦保健市場中佔據相當大的佔有率

在併發症中，妊娠糖尿病細分市場預計將在全球孕產婦保健市場中佔據相當大的佔有率。這一細分市場的成長歸因於該地區人口中妊娠糖尿病盛行率的不斷上升。妊娠糖尿病可以透過飲食、運動來控制，在某些情況下還可以根據嚴重程度進行胰島素治療。一種稱為糖尿病的慢性（長期）疾病會影響身體將食物轉化為能量的方式。妊娠糖尿病治療的目標是維持與未患有此疾病的孕婦相當的血糖值。特殊飲食方案、規律運動計畫、每日血糖測試和胰島素注射都是治療的一部分。根據美國疾病管制與預防中心的數據，如果女性沒有患有糖尿病，她在懷孕期間可能會患上妊娠糖尿病。在美國，妊娠糖尿病每年影響 2% 至 10% 的懷孕。維持妊娠糖尿病的控制可確保安全懷孕和健康分娩。

區域展望

全球孕產婦保健市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於公眾健康意識的增強和對創新醫療技術需求的增加，預計亞太地區將在全球市場中佔據顯著佔有率。

北美地區預計全球孕產婦保健市場年複合成長率顯著成長

在所有地區中，預計北美在預測期內將以相當大的年複合成長率成長。區域成長歸因於該地區對計劃生育的需求不斷成長。有機會利用避孕和計劃生育服務的婦女可以間隔懷孕並降低困難的風險。因此，市場參與者正在推出新產品來滿足孕產婦死亡率的需求。據美國疾病管制與預防中心稱，這份報告更新了先前的一份報告，該報告顯示了2018 年至2020 年的孕產婦死亡率。在美國，2021 年有1,205 名婦女因懷孕相關原因死亡，而2021 年為861 名。2020 年和2019 年分別為754 例。與2020 年每10 萬名活產 23.8 例死亡和2019 年每10 萬名活產 20.1 例死亡相比，2021 年孕產婦死亡率為32.999例。 2021 年，非西班牙裔黑人（即黑人）女性的孕產婦死亡率為每 10 萬活產 69.9 人，是非西班牙裔白人（即白人）女性死亡率（26.6 人）的 2.6 倍。黑人女性的發生率明顯高於白人和西班牙裔女性。 2020 年至 2021 年間，西班牙裔和所有其他種族群體的人數顯著增加。

2018年，孕產婦死亡率為每10萬活產兒17.4人死亡，2019年為每10萬活產兒20.1人死亡，2020年為每10萬活產兒23.8人死亡，2021年為每10萬活產人32.9人死亡。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Agile Therapeutics, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Boston MedTech Advisors, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • MCH Ventures, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按類型分類的全球孕產婦保健市場
    • 宮內
    • 異位
    • 輸卵管
    • 其他（腹腔內妊娠、單胞胎妊娠、多胞胎妊娠）
  • 全球孕產婦保健市場的複雜情況
    • 流產
    • 早產和分娩
    • 子癇前症
    • 妊娠糖尿病
    • 前置胎盤
    • 其他（嚴重出血和感染）
  • 按護理分類的全球孕產婦保健市場
    • 產前護理
    • 產後護理

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Apollo Hospitals Enterprise Ltd.
  • Ann & Robert H. Lurie Children's Hospital of Chicago
  • Cincinnati Children's Hospital Medical Center
  • Fuji Latex Co., Ltd.
  • Jiovio Healthcare
  • Johnson & Johnson Services, Inc.
  • March of Dimes
  • McKinsey & Co.
  • MedTech Boston
  • Merck & Co., Inc.
  • Okamoto Industries Co., Ltd.
  • RAND Corp.
  • Reckitt Benckiser Group
  • Sanofi
Product Code: OMR2027591

Title: Global Maternal Health Market Size, Share & Trends Analysis Report by Type (Intrauterine, Ectopic, Tubal, and Others), by Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others), and by care (Prenatal Care, and Postnatal Care),Forecast Period (2023-2030).

The global Maternal Health market is anticipated to grow at a CAGR of 9.0% during the forecast period (2023-2030). The growth of the market is attributed to the growing demand for adopting evidence-based best practices that can lead to better maternal and infant health outcomes. Nowadays, hospitals that have adopted the highest standards in terms of patient care quality, safety, and accessibility for pregnant and postpartum patients have been awarded a certification that informs consumers about the establishments. Accordingly, market players are coming up with new products to cater to the demand for new programs. For instance, in 2022, the Centers for Medicare & Medicaid Services (CMS) launched a new programme within its maternity and baby health programme aimed at reducing low-risk caesarean deliveries in order to enhance both infant and maternal health. The core of this programme is a learning collaborative that provides Medicaid and CHIP agencies with strategies to prevent low-risk caesarean deliveries and works directly with states to adopt research-proven best practices in their state.

Segmental Outlook

The global maternal health market is segmented by type, complication, and care. Based on type, the market is sub-segmented into intrauterine, ectopic, tubal, and others. Based on the complications, the market is sub-segmented into miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa, and others. Further, on the basis of care, the market is sub-segmented into prenatal care and postnatal care. Among the complications, the miscarriage sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for maternal health care as a result of an increase in miscarriages across the globe. For instance, in 2022, according to the National Institute of Health (NIH), The probability of miscarriage in women aged 20 to 30 at fewer than 20 weeks' gestation is 8.9%. When it comes to women over 40, this rises to 74.7%. Prior obstetrical history is a significant predictor of early pregnancy loss risk. After one loss, two consecutive miscarriages, or three or more consecutive miscarriages, the chance of miscarriage in a subsequent pregnancy is approximately 20%, 28%, and 43%, respectively.

The Gestational Diabetes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Maternal Health Market

Among the complications, the gestational diabetes sub-segment is expected to hold a considerable share of the global maternal health market. The segmental growth is attributed to growing prevalence of gestation diabetes among population across the region. Gestational diabetes can be controlled with diet, exercise, and, in some cases, insulin therapy, depending on the severity. A chronic (long-lasting) medical condition called diabetes affects how the body converts food into energy. The goal of gestational diabetes treatment is to maintain blood glucose levels that are comparable to those of pregnant women without the condition. Special meal regimens, regular exercise schedules, daily blood glucose tests, and insulin injections are all part of the treatment. According to the Centers for Disease Control and Prevention, if a woman is not suffering from diabetes, she can develop gestational diabetes during pregnancy. Gestational diabetes affects somewhere between 2% and 10% of pregnancies each year in the US. Maintaining control of gestational diabetes ensures a safe pregnancy and a healthy delivery.

Regional Outlook

The global Maternal Health market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increase in public health consciousness and a rise in demand for innovative medical technologies.

The North America Region is Expected to Grow at a Significant CAGR in the Global Maternal Health Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing demand for family planning across the region. Women who possess the opportunity to utilize contraception and family planning services can space their pregnancies and lower their risk of difficulties. Accordingly, market players are coming up with new products to cater to the demand for maternal death rates. According to the Centers for Disease Control and Prevention, this report updates an earlier one that showed maternal death rates for the years 2018 to 2020. In the US, 1,205 women passed away owing to pregnancy-related causes in 2021, as opposed to 861 in 2020 and 754 in 2019. Compared to rates of 23.8 deaths per 100,000 live births in 2020 and 20.1 deaths per 100,000 live births in 2019, the maternal mortality rate for 2021 was 32.9. In 2021, non-Hispanic Black (thus, Black) women had a maternal mortality rate of 69.9 deaths per 100,000 live births, that was 2.6 times higher than the rate for non-Hispanic White (thus, White) women (26.6). Black women's rates were significantly higher than those of White and Hispanic women. Between 2020 and 2021, there were significant increases in individuals of Hispanic heritage and all other racial groups.

In 2018, the maternal mortality rate was 17.4 deaths per 100,000 live births, in 2019 it was 20.1 deaths per 100,000 live births, in 2020 it was 23.8 deaths per 100,000 live births, and in 2021 it was 32.9 deaths per 100,000 live births.

Market Players Outlook

The major companies serving the Maternal Health market include: Agile Therapeutics, Inc., Boston MedTech Advisors, Inc., Fuji Latex Co., Ltd., Johnson & Johnson Services, Inc., March of Dimes and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, The New Jersey Health Care Quality Institute, in partnership with the Burke Foundation, launched the Maternal Infant Health (MIH) Hub, an innovative policy and learning partnership with a mission to advance midwifery practice in New Jersey while enhancing maternal/infant health and reducing racial/ethnic inequities.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global maternal health market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Agile Therapeutics, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Boston MedTech Advisors, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. MCH Ventures, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Maternal Health Market by Type
    • 4.1.1. Intrauterine
    • 4.1.2. Ectopic
    • 4.1.3. Tubal
    • 4.1.4. Others (Intra-Abdominal Pregnancy, Singlet Pregnancy, Multiple Pregnancy)
  • 4.2. Global Maternal Health Market by Complication
    • 4.2.1. Miscarriage
    • 4.2.2. Premature Labor & Birth
    • 4.2.3. Preeclampsia
    • 4.2.4. Gestational Diabetes
    • 4.2.5. Placenta Previa
    • 4.2.6. Others (Severe Bleeding, and Infections)
  • 4.3. Global Maternal Health Market by Care
    • 4.3.1. Prenatal Care
    • 4.3.2. Postnatal Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Apollo Hospitals Enterprise Ltd.
  • 6.2. Ann & Robert H. Lurie Children's Hospital of Chicago
  • 6.3. Cincinnati Children's Hospital Medical Center
  • 6.4. Fuji Latex Co., Ltd.
  • 6.5. Jiovio Healthcare
  • 6.6. Johnson & Johnson Services, Inc.
  • 6.7. March of Dimes
  • 6.8. McKinsey & Co.
  • 6.9. MedTech Boston
  • 6.10. Merck & Co., Inc.
  • 6.11. Okamoto Industries Co., Ltd.
  • 6.12. RAND Corp.
  • 6.13. Reckitt Benckiser Group
  • 6.14. Sanofi

LIST OF TABLES

  • 1. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 24. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MATERNAL HEALTH MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MATERNAL HEALTH MARKET SHARE BY COMPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MATERNAL HEALTH MARKET SHARE ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)